New Document top_band
 
Business Standard

Analysts' corner

Dr Reddy's Labs & Indraprastha Gas

Read more on:    Indraprastha Gas | Dr Reddys Labs
Related News

DR REDDY’S LABS
Reco price: Rs 1,709;
Target price: Rs 1,950
Dr Reddy’s (DRRD) has filed an abbreviated new drug application for singulair granules oral formulation, used for treatment of asthma in children. Innovator Merck has sued DRRD for infringement of a patent on this, which expires in October 2022. This product has $80 million annual sales in the US. DRRD can launch earliest in September 14, after expiry of a 30-month stay on generic launch. Mylan and Teva could be the first to file on this product. Overweight.

HSBC Global Research


Reco price: Rs 346;
Target price: Rs 426
The Petroleum and Natural Gas Regulatory Board (PNGRB) has issued an order on network rates and compression charge for Indraprastha Gas (IGL);. Against IGL’s proposed Rs 7.8/scm of network rate and compression charge, the PNGRB has allowed a mere Rs 3.1/scm, a decline of Rs 4.7/scm. Even after allowing for a marketing margin over and above this (the quantum of which, however, is uncertain), the order comes as a significant negative surprise, leading to a potential downside of 45-65 per cent to Citigroup’s Ebitda. Under this scenario, IGL will struggle to make even normative returns on the capital it has invested in the business. Maintain buy.

Citigroup

Read more on:   
|

Read More

Axis Bank: Concerns reflect in valuations

Axis Bank posted good set of numbers for the quarter ended 31st March 2012, beating the consensus estimates. Higher than expected growth in interest ...

Quick Links

 

Market News

Mid- and small-cap stocks see post-Budget blues

Underperform bluechips in recent rally

Pharma stocks could rise another 15-20 per cent

Expectations of strong results, consistent performance and investors preference for stocks in the defensive space help the sector outshine ...

Sweet spot for consumers

At a time when nobody on markets is putting even his loose change on real estate stocks, the one company that has got me to alter my bias is ...

The IPO comeback kids

Earlier this month, Lavasa Corp filed its IPO document with Sebi, reviving its four-year-old plan to tap the capital market

Devangshu Datta: Policy triggers and wild cards

RBI's August policy review and the course of the West Asian crisis will determine market movements in the short run

Back to Top